Sales rise 31.40% to Rs 452.16 crore
Net profit of Nectar Lifescience reported to Rs 1.57 crore in the quarter ended December 2023 as against net loss of Rs 9.29 crore during the previous quarter ended December 2022. Sales rose 31.40% to Rs 452.16 crore in the quarter ended December 2023 as against Rs 344.12 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales452.16344.12 31 OPM %9.330.42 -PBDT17.83-2.78 LP PBT2.46-17.56 LP NP1.57-9.29 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content